Can amino acids shield kidneys during life support?
NCT ID NCT07438262
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving amino acids (protein building blocks) through a vein can help prevent or reduce acute kidney injury in adults on ECMO life support in the ICU. About 40 participants will receive either amino acids or a placebo. The goal is to see if this simple treatment can improve kidney function and outcomes in critically ill patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alfred Hospital
Melbourne, Victoria, 3004, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound-Guided diuretic strategy may boost kidney recovery after cardiac surgery
- A simple urine test and a smart alert may help predict kidney failure in sick kids
- The hidden price tag of kidney injury after heart surgery
- A common amino acid may shield kidneys after heart surgery — a massive analysis puts it to the test
- Urine biomarkers may spot kidney damage before standard tests do
- Urine test after a single dose of furosemide may spot kidney danger in ICU patients